Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE
- Conditions
- Migraine Disorders
- Interventions
- Device: Occipital nerve stimulator
- First Posted Date
- 2013-01-25
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 28
- Registration Number
- NCT01775735
- Locations
- 🇺🇸
Boston Scientific Clinical Research Information Toll Free Number, Valencia, California, United States
🇺🇸University of Illinois at Chicago (Implanting Physician), Chicago, Illinois, United States
🇺🇸Diamond Headache Clinic (Headache Physician), Chicago, Illinois, United States
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
- Conditions
- Pancreatic Carcinoma
- Interventions
- Device: WallFlex™ Biliary RX Fully Covered/Uncovered Stent System
- First Posted Date
- 2013-01-23
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 284
- Registration Number
- NCT01774019
- Locations
- 🇺🇸
Standford University Medical Center, Stanford, California, United States
🇦🇺Westmead Hospital, Westmead, New South Wales, Australia
🇧🇪ULB Erasme Hospital, Brussels, Belgium
Safety and Performance Study of the Reliance 4-Front Lead
- Conditions
- Tachycardia
- Interventions
- Device: Reliance 4-Front lead implantation
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 167
- Registration Number
- NCT01772576
- Locations
- 🇦🇹
Landesklinikum St. Poelten, St. Pölten, Austria
🇨🇳Queen Mary Hospital, Hong Kong, China
🇩🇰Aarhus University Hospitals, Aarhus, Denmark
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
- Conditions
- Permanent Atrial Fibrillation
- First Posted Date
- 2013-01-10
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 25
- Registration Number
- NCT01765075
- Locations
- 🇨🇿
Na Homolce, Prague, Czech Republic
🇬🇧Guys & St. Thomas' Hospital, London, United Kingdom
Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology
- Conditions
- Atrial Fibrillation
- Interventions
- Device: WATCHMAN LAA Closure Technology
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 576
- Registration Number
- NCT01760291
- Locations
- 🇺🇸
Arizona Heart Rhythm Research Center, Phoenix, Arizona, United States
🇺🇸Central Baptist Hospital, Lexington, Kentucky, United States
🇺🇸Mount Sinai Medical Center, New York, New York, United States
S-ICD® System Post Approval Study
- Conditions
- Primary Prevention of Sudden Cardiac ArrestSecondary Prevention of Sudden Cardiac Arrest
- Interventions
- Device: S-ICD System
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1766
- Registration Number
- NCT01736618
- Locations
- 🇺🇸
Heart Center Research, LLC, Huntsville, Alabama, United States
🇺🇸Cardiovascular Associates of Mesa, Mesa, Arizona, United States
🇺🇸Phoenix Cardiovascular Group, Phoenix, Arizona, United States
IntellaTip MiFi XP Ablation Catheter Trial
- Conditions
- Atrial Flutter
- Interventions
- Device: IntellaTip MiFi XP Catheter
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 10
- Registration Number
- NCT01730807
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- Conditions
- Pain
- Interventions
- Device: neurostimulation system
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 4800
- Registration Number
- NCT01719055
- Locations
- 🇺🇸
Michigan Pain Specialists, Ann Arbor, Michigan, United States
🇺🇸Physicians Research Group, LLC, Phoenix, Arizona, United States
🇺🇸Hope Research Institute, Las Vegas, Nevada, United States
Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2
- Conditions
- Bradyarrhythmia
- First Posted Date
- 2012-10-29
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 514
- Registration Number
- NCT01715558
- Locations
- 🇧🇪
Ziekenhuis Oost Limburg, Genk, Belgium
🇧🇪Hartcentrum Hasselt Jessa Ziekenhuis Campus Virga Jesse, Hasselt, Belgium
🇩🇰Regionshospitalet Herning, Herning, Denmark
Evaluation of PCLs Using Three EUS-FNA Needles
- Conditions
- Pancreatic Cystic Lesions
- Interventions
- Device: 22 G NeedleDevice: 19 G Flex NeedleDevice: 19 G Needle
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 250
- Registration Number
- NCT01711294
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸Indiana University Medical Center, Indianapolis, Indiana, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States